UNSPSC 41131726: Prothrombin consumption test

In this classification a prothrombin consumption tests is a device that measures the patient's capacity to generate thromboplastin in the coagulation process. The test also is an indirect indicator of qualitative or quantitative platelet abnormalities US FDA regulates Prothrombin consumption test under 21 CFR 864.7720 and under FDA product code MIF.

UNSPSC 41131726 Prothrombin consumption test is a Commodity code that in recent state and local procurement activity encompasses drug and alcohol testing services, laboratory testing supplies, and related clinical diagnostics—a scope notably broader than the code's nominal name. State and local buying under this code spans county corrections and criminal justice departments, public health agencies, cities, counties, and specialized districts. Collin County, Texas has solicited drug testing services for offender supervision twice in the recent posting window, indicating repeat procurement activity under this code. The work includes immunoassay screening with confirmation testing (LC/MS/MS, GC/MS), alternative testing modalities such as oral fluid and hair analysis, clinical laboratory services for comprehensive specimen processing, and forensic drug standards for toxicology validation. Issuing bodies range from county community supervision departments (Collin County, Benton County) to county health services (Collin County, Bernalillo County), state purchasing divisions (Texas Comptroller), county forensic laboratories (Pinellas County), and municipal government (City of Charlotte). Collin County appears as a particularly active buyer, with separate RFPs for offender drug testing and laboratory services both posted in recent months.

Geographic activity concentrates in Texas, with additional recent solicitation activity in Georgia (Gwinnett County), Oregon (Benton County and State of Oregon), Florida (Seminole County, Pinellas County), and North Carolina (Charlotte). Collin County Community Supervision and Corrections Department issued RFP 2026-327 for offender specimen collection and drug testing services with an estimated annual value of $600,000 and a response deadline of July 23, 2026, covering immunoassay screening and LC/MS/MS or GC/MS confirmation across two sites in Plano and McKinney with approximately 25,031 tests annually. Benton County, Oregon solicited urinalysis testing for its Family Treatment Court Program through a formal RFP with proposals due July 7, 2026, requiring CLIA-certified laboratory services and twice-weekly testing with secure web-based result reporting. Pinellas County, Florida in partnership with the Florida Department of Law Enforcement procured certified drug reference standards (131 line items) for forensic laboratory validation and analysis through ITQ 26-0305-ITQ due April 23, 2026, with $49,034 in available federal funding from the Paul Coverdell Forensic Sciences Improvement Act. The Texas Comptroller of Public Accounts Statewide Procurement Division issued IFB 304T-27-175A1.1 for proprietary laboratory consumables and reagents for DNA analysis and drug screening from specified manufacturers, with proposals due October 20, 2026.